Does metformin augment the ovulation inducing effects of clomiphene in non-obese women with polycystic ovary syndrome?

Journal of the Indian Medical Association

Volumn 106, Issue 10, 2008, Pages 643-648

  Chaudhury, Kalyansree ^a   Chaudhury, Sudeshna ^b   Chowdhury, Subhankar ^c  

^a Department of Obstetrics and Gynaecology ^*  (India)

^b Ramkrishna Sarada Mission Matri Bhavan   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anovulation; Clomiphene response; Hyperinsulinaemia; Insulin resistance; Insulin sensitising agent metformin; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE; FOLIC ACID; METFORMIN; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY;

EID: 60549089437     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Frank S - Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-61.
2. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group - Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome: Revised 2003. Hum Reprod 2004; 19: 41-7.
3. Baillargeon JP, Iuorno MJ, Nestler JE - Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol 2003; 46: 325-40.
4. Carmina E, Lobo RA - Polycystic ovary syndrome: arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897-9.
5. Legro RS, Kunselman AR, Dodson WC, Dunaif A - Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84:165-9.
6. Dunaif A, Futterweit W, Segal KR, Dobrjansky A - Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome. Diabetes 1989; 38: 1165-74.
7. Rajkhowa M, Bicknell J, Jones M, Clayton RN - Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. Fertil Steril 1994; 61: 605-12.
8. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F - Insulin stimulates testerone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998; 83: 2001-5.
9. Gilling-Smith C, Story H, Rogers V, Franks S - Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997; 47: 93-9.
10. Pasquali R, Gambineri A - Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 2006; 154: 763-75.
11. Velaquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ - Metformin therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, hyperandrogénaemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-54.
12. Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A - Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 1998; 138: 269-74.
13. Chuni N - Efficacy of sequential treatment of metformin and clomiphene citrate in clomiphene resistant women with polycystic ovary syndrome. J Obstet Gynaecol India 2007; 57: 69-72.
14. Lord JM, Flight IHK, Norman RJ - Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database, 2003.
15. El-Biely MM, Habba M - The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome. Middle East Fertil Soc J 2001; 6: 43-9.
16. Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez-armas O, Rivas-santiago A, Koistinen H, et al - Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentration enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 1126-33.
17. Gysler MG, March CM, Mishell DR, Bailey EJ - A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982; 37: 161-7.
18. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE - Metformin increases the ovulatory rate and pregnancy rate from clomifene citrate in patients with polycystic ovary syndrome who are resistant to clomifene citrate alone. Fertil Steril 2001; 75: 310-5.
19. Nestler JE, Jakubowic DJ, Evans WS, Pasquali R - Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-80.
20. Murakawa H, Hasegawa I, Kurabayashi T, Tanaka K - Polycystic ovary syndrome, insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med 1999; 44: 23-7.